WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of $0.17, $0.34 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $83.75 million versus the consensus estimate of $20.72 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.